Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 3
- 试验地点
- 1
- 主要终点
- dosimetry (measurement of the absorbed dose, delivered to prostate, by ionizing radiation)
研究概览
简要总结
This study evaluates the dose received by the prostate with in vivo dosimetry when delivering image guided radiation therapy (IGRT) associated with intensity modulated radiation therapy (IMRT) for patients with localized prostate cancer using two repositioning techniques: fiduciary markers or soft tissues.
详细描述
10 participants will receive a cone beam computed tomography (CBCT) repositioning, while the other 10 will receive a kV imaging of fiducial marker repositioning. The principal objective is to evaluate and compare the dose received by the prostate using two repositioning techniques.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •male > 18 years
- •carcinoma of the prostate histologically confirmed
- •localized stage
- •favorable, intermediate and unfavorable groups according to NCCN or D'Amico classification
- •patients must have signed a written informed consent form
- •patients must be affiliated to a Social Health Insurance.
排除标准
- •metastasis
- •indication for pelvic radiation
- •anticoagulant therapy
- •lateral or bilateral hip replacement
- •patient receiving an adult protective services
- •Patient unable to comply with the required medical follow-up for geographic, social or psychological reasons
研究组 & 干预措施
CBCT
cone beam computed tomography (CBCT) repositioning
干预措施: CBCT (Other)
CBCT
cone beam computed tomography (CBCT) repositioning
干预措施: IGRT Associated With IMRT (Radiation)
fiducial markers
kV imaging of fiducial marker repositioning
干预措施: fiducial marker (kV imaging) (Other)
fiducial markers
kV imaging of fiducial marker repositioning
干预措施: IGRT Associated With IMRT (Radiation)
结局指标
主要结局
dosimetry (measurement of the absorbed dose, delivered to prostate, by ionizing radiation)
时间窗: 8 weeks
次要结局
未报告次要终点